MBB Public Markets’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
MBB Public Markets's XBI Position: Q4 2024 in Review
MBB Public Markets sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2024, closing a stake of 209,271 shares — an estimated $20.7M sold.
MBB Public Markets first reported a position in XBI in Q4 2021 and held it in 12 quarters. The position peaked at $62.3M in Q2 2022. 738 funds tracked by Wall St. Rank hold XBI as of Q4 2024.
- MBB Public Markets reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2024 after selling out during the quarter.
- MBB Public Markets sold 209,271 State Street SPDR S&P Biotech ETF shares in Q4 2024, an estimated $20.7M.
- MBB Public Markets first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and held it in 12 quarters.
- MBB Public Markets's State Street SPDR S&P Biotech ETF position peaked at $62.3M in Q2 2022.
- 738 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2024.
Based on MBB Public Markets's 13F filing for Q4 2024, filed 14 Feb 2025.